WEBINAR ENDED
WEBINAR DETAILS
  • About
    FG001 is proven safe in patients undergoing surgery for cancer – a significant milestone for FluoGuide to further advance clinical development in aggressive brain cancer and in a prevalent indication.

    This investor call will allow investors to learn more about the news announced on October 8, 2021.
  • Agenda
    • Presentation of safety data
    • Future outlook
    • Q&A
  • Duration
    1 hour
  • Price
    Free
  • Language
    English
  • OPEN TO
    Everyone
  • Dial-in Number
    Please register for this Webinar to view the dial-in info.
FEATURED PRESENTERS
  • Webinar hosting presenter

    Morten Albrechtsen

    CEO of FluoGuide
    Morten Albrechtsen is an MD and BBA (‘HD’ in marketing, CBS). Morten is a seasoned entrepreneur with a strong medical, commercial and financial background. The expertise is gained within a broad range of therapeutic areas and with both drugs and...
    Full Profile
  • Webinar hosting presenter

    Andreas Kjær

    CMO of FluoGuide
    Andreas Kjaer, is an MD, PhD, DMSc and professor at the University of Copenhagen and chief physician at Rigshospitalet, the National University Hospital of Denmark. His research is focused on molecular imaging with PET and PET/MRI in cancer and...
    Full Profile
HOSTED BY
ATTENDED (40)
Powered by BigMarker